Hepatitis C Virus Dynamics during Natural Infection Are Associated with Long-Term Histological Outcome of Chronic Hepatitis C Disease

Sullivan, Daniel G.; Bruden, Dana; Deubner, Heike; McArdle, Susan; Chung, Minjun; Christensen, Carol; Hennessy, Thomas; Homan, Chriss; Williams, James; McMahon, Brian J.; Gretch, David R.
July 2007
Journal of Infectious Diseases;7/15/2007, Vol. 196 Issue 2, p239
Academic Journal
Background. The long-term dynamics of hepatitis C virus (HCV) infection and their association with hepatitis C disease are unknown. Methods. Fifty-two treatment-naive subjects with chronic HCV genotype 1 infection were selected from the Alaska Natives and American Indians cohort. Viral RNA levels were measured in 223 specimens (mean, 4.3 specimens/subject) over 457 patient-years. Viral quasispecies diversity was analyzed in 187 specimens (mean, 3.6 specimens/subject) over 365 patient-years. Results. Thirty-three subjects had minimal hepatic fibrosis, and 19 developed bridging fibrosis or cirrhosis. There was no significant difference in host variables, including alcohol consumption, between disease groups. Subjects with mild disease had higher serum RNA levels after 2 decades of infection (P = .013), greater fluctuations in RNA levels over time (P = .004), higher intraspecimen quasispecies diversity (P = .001), and higher rates of quasispecies diversification (P = .004) than did subjects with severe disease. On multivariate analysis, the odds of having severe disease were 15.3 (95% confidence interval, 2.3-99.6) times higher among persons with low quasispecies diversification rates compared with the odds among persons with high diversification rates. Conclusions. Histological progression of hepatitis C is tightly associated with homogenization of HCV quasispecies, perhaps reflecting immune failure and/or selective outgrowth of aggressive viral variants.


Related Articles

  • Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort.  // Genome Medicine;2011, Vol. 3 Issue 7, p273 

    The article offers information on the usage of interleukin 28A (IL28A) single nucleotide polymorphisms (SNPs) and haplotypes for the identification of drug response related to the treatment of hepatitis C. It offers information on hepatitis C virus (HCV) that cause severe disease in liver. It...

  • Genotypes of HCV in hepatitis C patients of Han nationality in Gansu, China. PENG Xuebin; MAO Xiaorong; CHEN Hong // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;nov2013, Vol. 29 Issue 11, p828 

    Objective To investigate the genotypes of hepatitis C virus ( HCV ) among the hepatitis C patients of Han nationality in Gansu, China, as well as their possible routes of transmission ad relationship with clinical indices. Methods The complete data regarding hepatitis C, including sex, age,...

  • Association of laboratory parameters with viral factors in patients with hepatitis C.  // Virology Journal;2011, Vol. 8 Issue 1, p361 

    The article focuses on a cross-sectional and observational study of patients infected with hepatitis C virus (HCV). HCV RNA positive patients were chosen in the study who were divided into three cohorts to validate the data. The study found that all genotypes except 4a have no association with...

  • Overview. Brechot, C. // Oncogene;6/26/2006, Vol. 25 Issue 27, p3755 

    The article provides information about hepatocellular carcinoma (HCC), a histopathological form of primary liver cancer. HCC is a major long-term complication of chronic hepatitis and cirrhosis. Research on hepatitis B virus and hepatitis C virus-related liver carcinogenesis have enabled...

  • TMC435 Effective in the Treatment of HCV Genotype 1 Infection. Butterman, Eric // MD Conference Express;Dec2011, p14 

    The article discusses the effectiveness of TMC435, an oral inhibitor of hepatitis C virus (HCV) in the treatment of HCV genotype 1 infection. Clinical trials are done to determine the efficacy, safety and tolerability of different regimens of TMC435. It also compares the standard treatment to...

  • Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice. Chevaliez, St├ęphane; Bouvier-Alias, Magali; Brillet, Rozenn; Pawlotsky, Jean-Michel // PLoS ONE;2009, Vol. 4 Issue 12, p1 

    Background: With the development of new specific inhibitors of hepatitis C virus (HCV) enzymes and functions that may yield different antiviral responses and resistance profiles according to the HCV subtype, correct HCV genotype 1 subtype identification is mandatory in clinical trials for...

  • The Spectrum of Chronic Hepatitis C Virus Infection in the Virginia Correctional System: Development of a Strategy for the Evaluation and Treatment of Inmates with HCV. Sterling, Richard K.; Brown, Robert S.; Hofmann, Charlotte M.; Luketic, Velimir A.; Stravitz, R. Todd; Sanyal, Arun J.; Contos, Melissa J.; Mills, A. Scott; Smith, Vernon; Shiffman, Mitchell L. // American Journal of Gastroenterology;Feb2005, Vol. 100 Issue 2, p313 

    BACKGROUND AND OBJECTIVE: Chronic hepatitis C virus (HCV) is common in the inmate population of the United States. Long-standing HCV can progress to cirrhosis, which can contribute to significant morbidity and mortality. However, those inmates with histologically mild disease are unlikely to...

  • Serotyping and Genotyping of Hepatitis C Virus in Belgium. De Cock, L.; Vranckx, R. // Infection; 

    Background: Given that both pathogenicity and the response to treatment are possibly associated with hepatitis C virus (HCV) serotype, it appeared sensible to establish the prevalence of the different HCV types in Belgium. Materials and Methods: The HCV serotypes were determined in 68 HCV-RNA...

  • Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome. Bortolotti, F.; Resti, M.; Marcellini, M.; Giacchino, R.; Verucchi, G.; Nebbia, G.; Zancan, L.; Marazzi, M. G.; Barbera, C.; Maccabruni, A.; Zuin, G.; Maggiore, G.; Balli, F.; Vajro, P.; Lepore, L.; Molesini, M.; Guido, M.; Bartolacci, S.; Noventa, F. // Gut;Jun2005, Vol. 54 Issue 6, p852 

    Background and aim: Little is known of hepatitis C virus (HCV) genotypes in HCV infected children. This retrospective, multicentre study investigated genotype distribution and correlation with clinical features and outcome in a large series of Italian children. Methods: Between 1990 and 2002,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics